Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript October 30, 2025
Agios Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.78, expectations were $-1.93.
Operator: Good morning, and welcome to Agios Pharmaceuticals Third Quarter 2025 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at Agios’ request. I would now like to turn the call over to Morgan Sanford, Head of Investor Relations at Agios. Please go...
